Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
1
institution
Market cap
$508.0M
46M shares
52-week range
$9.72 – $20.36
15% from low
Sector
OIL & GAS FIELD SERVICES, NEC
Exchange
NYSE
CS
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $700.8M | $668.2M | $487.3M | $470.3M | $489.7M | $509.8M | $523.8M | $526.5M |
| Cost of revenue | $520.1M | $495.6M | $385.1M | $386.4M | $410.8M | $415.7M | $435.5M | $432.2M |
| Gross profit | $180.8M | $172.6M | $102.1M | $83.8M | $78.9M | $94.0M | $88.4M | $94.3M |
| Gross margin | 25.8% | 25.8% | 21.0% | 17.8% | 16.1% | 18.4% | 16.9% | 17.9% |
| R&D | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Operating income | $118.6M | $96.7M | −$76.8M | $45.3M | $41.5M | $54.6M | $58.6M | $50.5M |
| EBITDA | $141.7M | $124.6M | $70.5M | $63.8M | $58.7M | $70.4M | $73.5M | $71.1M |
| Net income | $79.5M | $102.0M | −$97.6M | $19.7M | $19.5M | $36.7M | $31.4M | $29.7M |
| Net margin | 11.3% | 15.3% | -20.0% | 4.2% | 4.0% | 7.2% | 6.0% | 5.6% |
| EPS (diluted) | 1.79 | 2.10 | -2.16 | 0.42 | 0.42 | 0.77 | 0.66 | 0.68 |
Annual figures · source: Financial Modeling Prep
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $518M | $0.60 | $0.58–$0.61 | 1 |
| 2027 | $547M | $0.85 | $0.84–$0.85 | 1 |
| 2028 | $623M | $1.48 | $1.48–$1.48 | 1 |
Forward consensus · source: Financial Modeling Prep
Core Laboratories Inc is a providers of proprietary and patented reservoir description and production enhancement services and products to the oil and gas industry, through client relationships. The company operates its business in two segments; Reservoir Description, and Production Enhancement. It provides data and analytics to aid well operators in determining optimal methods for recovering, processing, and refining hydrocarbons from a well. It also manufactures the associated lab equipment for its services. The company generates majority of its revenue from Reservoir Description segment.
www.corelab.comNo one on the platform currently holds CLB.
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2026-03-31 | 50,603 | $849.6K |
| Ex-date | Per share | Pay date |
|---|---|---|
| 2026-05-11 | $0.0100 | 2026-06-01 |
| 2026-02-13 | $0.0100 | 2026-03-09 |
| 2025-11-03 | $0.0100 | 2025-11-24 |
| 2025-08-04 | $0.0100 | 2025-08-25 |
| 2025-05-05 | $0.0100 | 2025-05-27 |
| 2025-02-10 | $0.0100 | 2025-03-03 |
| 2024-11-04 | $0.0100 | 2024-11-25 |
| 2024-08-05 | $0.0100 | 2024-08-26 |
| 2024-05-03 | $0.0100 | 2024-05-28 |
| 2024-02-09 | $0.0100 | 2024-03-04 |
No one on the platform has traded CLB yet.
| $847M |
| — |
| NBRNabors Industries Ltd. | $83.76 | +1.39% | $1.2B | — |
| PDSPrecision Drilling Corporation | $76.84 | -1.03% | $994M | — |
Source: Financial Modeling Prep · peers by sector/industry
| 2023-11-10 |
| $0.0100 |
| 2023-12-04 |
| 2023-08-04 | $0.0100 | 2023-08-28 |
| Execution date | Ratio |
|---|---|
| 2010-07-09 | 2-for-1 |
Trading at 18.9× earnings vs its 29.4× historical median P/E.
Fair value ≈ $17.57 · price $11.29 today
Fair-value line = the stock's median historical P/E × earnings. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.
Click to see transaction details on SEC.gov. Form 4s cover trades by officers, directors, and 10%+ owners, due within 2 business days of the trade.
$CLB aligned red before lunch — day tag bearish and it's not bouncing
View on StockTwits ↗Wall St is expecting 0.11 EPS for $CLB Q2 [Reporting 07/29 AMC] http://www.estimize.com/intro/clb?chart=historical&metric_name=eps&utm_cont
View on StockTwits ↗Wall St is expecting 0.11 EPS for $CLB Q2 [Reporting 07/29 AMC] http://www.estimize.com/intro/clb?chart=historical&metric_name=eps&utm_cont
View on StockTwits ↗@a36er $CLB Core labs deals with oil wells, pressures, restart/completions, etc. Very interesting as well as $BOOM
View on StockTwits ↗$CLB Q1 '26 Earnings Results & Recap • Reported GAAP EPS of -$0.02 • Core Lab projects Q2 2026 revenue between $123.0 million and $131.0 million, with operating income from $6.4 million to $10.2 million, and EPS expected to range from $0.06 to $0.12.
View on StockTwits ↗Wall St is expecting 0.09 EPS for $CLB Q1 [Reporting 04/29 AMC] http://www.estimize.com/intro/clb?chart=historical&metric_name=eps&utm_cont
View on StockTwits ↗Wall St is expecting 0.13 EPS for $CLB Q1 [Reporting 04/29 AMC] http://www.estimize.com/intro/clb?chart=historical&metric_name=eps&utm_cont
View on StockTwits ↗Wall St is expecting 0.13 EPS for $CLB Q1 [Reporting 04/29 AMC] http://www.estimize.com/intro/clb?chart=historical&metric_name=eps&utm_cont
View on StockTwits ↗$CLB (-3.6% pre) Core Laboratories (NYSE: CLB) trims Q1 2026 guidance amid Middle East turmoil https://ooc.bz/l/97007
View on StockTwits ↗PickAlpha Evening Insights | 2026-03-23 - Trade Ideas For Tomorrow 1/3 Short $CLB — Tactical (1–5d) • Earnings Plan: Short CLB at next regular-session open to capture guidance-cut repricing over the next 1–3 sessions. Core Laboratories cut Q1 2026 guidance after the close, now expecting USD 119–123 mn revenue, much lower operating income and EPS of USD 0.05–0.07, citing Middle East conflict, customer delays and supply-chain disruptions. This directly undermines near-term earnings expectations and margins. Oilfield-services names typically reprice sharply to such negative pre-announcements, creating a tactical short opportunity in CLB. Risk: Exit if CLB closes above its next-session open on the next two sessions. • Valid until 2026-03-30 close (ET) Trade credibility: actionability ★★★★☆ | timeliness ★★★★☆ | clarity ★★★★☆
View on StockTwits ↗$APO $BARK $BNGO $CLB $AARD AFTER-HOURS MOVERS: Currently Higher After Earnings: - BARK (BARK) up 9.5% - Bionano Genomics (BNGO) up 2.1% Currently Lower After Earnings/Guidance: - Core Laboratories (CLB) down 4.6% after Q1 pre-announcement - Aardvark Therapeutics (AARD) down 1.5% Currently Also Lower: - Comtech Telecommunications (CMTL) down 0.6% after equity offering - Apollo Global Management (APO) down 2.6% after Bloomberg report of capped private equity redemptions
View on StockTwits ↗$CLB Core Laboratories sees Q1 EPS 5c-7c, two estimates 15c Sees Q1 revenue $119M-$123M, two estimates $125.4M. The company states: "At this time, due to regional instability, including client-driven project delays, travel constraints, and supply-chain disruptions, the Company expects first quarter 2026 revenue and earnings to be below its previously issued guidance provided on February 4, 2026. Changes in client activity levels across the Middle East are directly impacting operations in the countries where Core Lab operates. Damage to oil refining infrastructure and storage terminals has created capacity limitations, forcing operators to shut in or limit oil production. These effects have extended to regional supply chains and the maritime transportation of crude oil and refined products-particularly through the Strait of Hormuz-resulting in logistical constraints and delays in project execution. The impact has been more pronounced in Reservoir Description due to its unique role in supporting regional client studies, crude oil assay testing, and reservoir rock and fluid characterization, all of which rely on predictable field access, sample movement, and laboratory operations. Production Enhancement has been comparatively less affected; however, shipments of energetics products into certain parts of the region have been delayed or temporarily suspended."
View on StockTwits ↗$CLB I wonder what oil services companies are going to make all these repairs and restarts for wells and drilling? $BOOM
View on StockTwits ↗@cjwaters14 We're going to need every single piece of technology related to drilling more oil/gas possible. Agreed. $CLB is another.
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.